In gene therapy of Adenosine Deaminase $(ADA)$ deficiency,the patient requires periodic infusion of genetically engineered lymphocytes because

  • A
    Gene isolated from marrow cells producing $ADA$ is introduced into cells at embryonic stages.
  • B
    Lymphocytes from patient's blood are grown in culture,outside the body.
  • C
    Genetically engineered lymphocytes are not immortal cells.
  • D
    Retroviral vector is introduced into these lymphocytes.

Explore More

Similar Questions

In which bacteria was the insulin gene cloned?

At present,about $X$ recombinant therapeutics have been approved for human use the world over. Out of these,$Y$ are being marketed in India.

At present,about ........ recombinant therapeutics have been approved for human use the world over. Out of these,........ are being marketed in India.

Correct chronological order of the steps occurring during gene therapy are
$I$. Lymphocytes are obtained from the patients
$II$. Lymphocytes are transferred to the culture dishes
$III$. Lymphocytes are transfected with the normal $ADA$ genes
$IV$. The transfected cells are returned to the patients
The chronological order should be

Maturation of proinsulin into insulin takes place after

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo